Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas |
| |
Authors: | Hilde Dannenberg MD Paul Komminoth MD PhD Winand N. M. Dinjens PhD Ernst Jan M. Speel PhD Dr. Ronald R. de Krijger MD PhD |
| |
Affiliation: | (1) Institute of Pathology, Kantonsspital Baden, Switzerland;(2) Department of Molecular Cell Biology, GROW Research Institute, University of Maastricht, The Netherlands;(3) Erasmus MC, Josephine Nefkens Institute, Room Be 222, P. O. Box 1738, 3000 DR Rotterdam, The Netherlands |
| |
Abstract: | Pheochromocytomas and paragangliomas are neuroendocrine neoplasias of neural crest origin. Genetic mutations that are characterized in other human neoplasms are rarely seen in these tumors. About 10% of the patients with pheochromocytomas and paragangliomas present with a family history of von Hippel-Lindau disease (VHL), Multiple endocrine neoplasia type 2 (MEN2), one of the three familial paraganglioma syndromes (PGL; PGL1, PGL3, PGL4), or neurofibromatosis type 1 (NF1). In an even higher percentage, a genetic predisposition is involved in the development of these tumors. The genes of hereditary tumor syndromes such as the aforementioned ones are also ideal to study the molecular pathogenesis in the sporadic counterparts. Many studies have been undertaken to identify important secondary genetic events that contribute to the tumorigenesis of pheochromocytoma or paraganglioma, but a comprehensive review of these data is lacking. Recent findings of CGH and LOH studies provided new starting points to unravel the pathogenesis and progression of these tumors. This review presents an overview of our current understanding of the molecular pathogenesis of pheochromocytoma and paraganglioma. This work has been presented at the Endocrine Pathology Society meeting of the 92nd annual USCAP meeting in Washington DC, March 22, 2003. |
| |
Keywords: | Pheochromocytoma paraganglioma molecular pathogenesis RET VHL SDH CGH |
本文献已被 PubMed SpringerLink 等数据库收录! |
|